Y
Yotaro Izumi
Researcher at Saitama Medical University
Publications - 110
Citations - 12013
Yotaro Izumi is an academic researcher from Saitama Medical University. The author has contributed to research in topics: Lung cancer & Pneumonectomy. The author has an hindex of 26, co-authored 110 publications receiving 10486 citations. Previous affiliations of Yotaro Izumi include Keio University.
Papers
More filters
Journal ArticleDOI
Incidence of Pleural Recurrence after Computed Tomography-Guided Needle Biopsy in Stage I Lung Cancer
Keisuke Asakura,Yotaro Izumi,Yoshikane Yamauchi,Seishi Nakatsuka,Masanori Inoue,Hideki Yashiro,Takayuki Abe,Yuji Sato,Hiroaki Nomori +8 more
TL;DR: The pleural recurrence was not significantly increased after CTNB in p-stage I lung cancer patients in this particular study.
Journal ArticleDOI
Hemostatic efficacy of a recombinant thrombin-coated polyglycolic acid sheet coupled with liquid fibrinogen, evaluated in a canine model of pulmonary arterial hemorrhage.
Yotaro Izumi,Masatoshi Gika,Noriko Shinya,Sumika Miyabashira,Takayuki Imamura,Chikateru Nozaki,Masafumi Kawamura,Koichi Kobayashi +7 more
TL;DR: The hemostatic efficacy of TSF was superior to TC in this particular experiment, presumably because the adhesion was stronger, faster, and the sheet was more pliable in TSF compared with TC.
Journal ArticleDOI
Diagnostic Performance of Percutaneous Core-Needle Lung Biopsy Under CT Scan Fluoroscopic Guidance for Pulmonary Lesions Measuring ≤10 mm
Yoshikane Yamauchi,Yotaro Izumi,Seishi Nakatsuka,Masanori Inoue,Yuichiro Hayashi,Mitsutomo Kohno,Takashi Ohtsuka,Masaki Anraku,Taichiro Goto,Hiroaki Nomori +9 more
TL;DR: The authors applied most of the known elements of PV strategy (small tidal volume, low airway pressure and F io 2 , application of positive end-expiratory pressure) to see the total effect of PV strategies, and agree that all these factors may have affected the results to some degree.
Journal ArticleDOI
Safety of postoperative administration of human urinary trypsin inhibitor in lung cancer patients with idiopathic pulmonary fibrosis.
Yoshikane Yamauchi,Yotaro Izumi,Masanori Inoue,Hiroaki Sugiura,Taichiro Goto,Masaki Anraku,Takashi Ohtsuka,Mitsutomo Kohno,Kenzo Soejima,Hiroaki Nomori +9 more
TL;DR: Ulinastatin administration after lung resection in lung cancer patients with IPF was considered to be safe and feasible, and further study is planned at the highest dose of this study to evaluate efficacy.
Journal ArticleDOI
Airway administration of dexamethasone, 3=-5=-cyclic adenosine monophosphate, and isobutylmethylxanthine facilitates compensatory lung growth in adult mice
TL;DR: It is suggested that DCI facilitated compensatory lung growth, at least in part, through the induction of TTF-1, and DCI with further modifications may provide the material to potentially augment residual lung function after resection.